Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Bonjela Mouth Ulcer Gel
Active Ingredients: Choline bicarbonate 0%w/w
Choline salicylate 8.714%w/w
Salicylic acid 0%w/w
Dosage Form: Oral topical gel
New Zealand Sponsor: Reckitt Benckiser (New Zealand) Limited
Manufacturer: Reckitt Benckiser Healthcare (UK) Limited, Hull, North Humberside, United Kingdom
Product: Codral Chesty Cough Liquid
Active Ingredients: Bromhexine hydrochloride 0.6mg/mL
Guaiphenesin 20mg/mL
Dosage Form: Oral solution
New Zealand Sponsor: Pfizer Consumer Healthcare Division of Pfizer New Zealand Limited
Manufacturer: PharmAction Manufacturing Pty Limited, Laverton North, Victoria, Australia
Product: Codral Dry Cough Liquid
Active Ingredient: Pholcodine 1mg/mL
Dosage Form: Oral solution
New Zealand Sponsor: Pfizer Consumer Healthcare Division of Pfizer New Zealand Limited
Manufacturer: PharmAction Manufacturing Pty Limited, Laverton North, Victoria, Australia
Product: Prexige
Active Ingredient: Lumiracoxib 200mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturer: Novartis Pharma Stein AG, Stein, Switzerland
Product: Prexige
Active Ingredient: Lumiracoxib 400mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturer: Novartis Pharma Stein AG, Stein, Switzerland
Dated this 16th day of November 2004.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).